United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - montelukast sodium (unii: u1o3j18sfl) (montelukast - unii:mhm278sd3e) - montelukast 10 mg - montelukast sodium is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older. montelukast sodium is indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 2 years of age and older. montelukast sodium is indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older. hypersensitivity to any component of this product. pregnancy category b: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, montelukast sodium should be used during pregnancy only if clearly needed. teratogenic effect: no teratogenicity was observed in rats and rabbits at doses approximately 100 and 110 times, respectively, the maximum recommended daily oral dose in adults based on aucs [see nonclinical toxicology (13.2)]. during worldwide marketing

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - montelukast (unii: mhm278sd3e) (montelukast - unii:mhm278sd3e) - montelukast sodium chewable tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older. montelukast sodium chewable tablets are indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. sodium chewable tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 of age and older. because the benefits of montelukast sodium chewable tablets may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis , use for patients who have an inadequate response or intolerance to alternative therapies. montelukast sodium chewable tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older. because the ben

United States - English - NLM (National Library of Medicine)

direct rx - montelukast (unii: mhm278sd3e) (montelukast - unii:mhm278sd3e) - 1.1 asthma montelukast sodium chewable tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 2 years of age and older. 1.2 exercise-induced bronchoconstriction (eib) montelukast sodium chewable tablets are indicated for prevention of exercise-induced bronchoconstriction (eib) in patients 6 years of age and older. 1.3 allergic rhinitis montelukast sodium chewable tablets are indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in patients 2 years of age and older. because the benefits of montelukast sodium chewable tablets may not outweigh the risk of neuropsychiatric symptoms in patients with allergic rhinitis [see warnings and precautions (5.1)], reserve use for patients who have an inadequate response or intolerance to alternative therapies. • hypersensitivity to any component of this product. 8.1 pregnancy risk summary available data from published prospective and ret

Canada - English - Health Canada

dominion pharmacal - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Canada - English - Health Canada

dominion pharmacal - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers

Canada - English - Health Canada

dominion pharmacal - montelukast (montelukast sodium) - tablet - 10mg - montelukast (montelukast sodium) 10mg - leukotriene modifiers

Canada - English - Health Canada

laboratoire riva inc. - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Canada - English - Health Canada

laboratoire riva inc. - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers

Canada - English - Health Canada

pendopharm division of pharmascience inc - montelukast (montelukast sodium) - tablet (chewable) - 4mg - montelukast (montelukast sodium) 4mg - leukotriene modifiers

Canada - English - Health Canada

pendopharm division of pharmascience inc - montelukast (montelukast sodium) - tablet (chewable) - 5mg - montelukast (montelukast sodium) 5mg - leukotriene modifiers